5.82
+0.82(+16.40%)
Currency In USD
| Previous Close | 5 |
| Open | 5.49 |
| Day High | 5.86 |
| Day Low | 5.38 |
| 52-Week High | 5.86 |
| 52-Week Low | 2.03 |
| Volume | 285,221 |
| Average Volume | 143,045 |
| Market Cap | 304.78M |
| PE | -6.06 |
| EPS | -0.96 |
| Moving Average 50 Days | 4.02 |
| Moving Average 200 Days | 3.46 |
| Change | 0.82 |
If you invested $1000 in Sight Sciences, Inc. (SGHT) since IPO date, it would be worth $173.73 as of November 10, 2025 at a share price of $5.82. Whereas If you bought $1000 worth of Sight Sciences, Inc. (SGHT) shares 3 years ago, it would be worth $696.17 as of November 10, 2025 at a share price of $5.82.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer
GlobeNewswire Inc.
Nov 06, 2025 9:04 PM GMT
New leadership appointments strengthen Sight Sciences’ commitment to advancing our interventional dry eye initiatives and driving scalable operations and growthMENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT
Sight Sciences to Present at Two Upcoming Investor Conferences
GlobeNewswire Inc.
Nov 04, 2025 9:05 PM GMT
MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to t
Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025
GlobeNewswire Inc.
Oct 23, 2025 8:05 PM GMT
MENLO PARK, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to t